Skip to main content
. Author manuscript; available in PMC: 2010 Jul 27.
Published in final edited form as: Photochem Photobiol. 2010 May 13;86(4):949–954. doi: 10.1111/j.1751-1097.2010.00743.x

Figure 5. Effects of antioxidant and EGF-R inhibitor on UVB-mediated PAF-R agonist production in human skin.

Figure 5

Human skin explants were pretreated with 50 µL of a 10 mM solution of the antioxidant vitamin C, 4 mM of the EGF-R inhibitor PD168393, or vehicle alone (10% DMSO in ethanol) for 30 min before UVB (5,000 J/m2) irradiation. The epidermis was removed at one hour post-UVB treatment and lipids extracted and tested for PAF-R agonist activity in FURA-2-AM-loaded KBP cells. Data are the mean ± SE percentage of maximal peak calcium flux induced by 1 µM CPAF and numbers of explants tested from each treatment noted in parentheses. * Denotes statistically significant (p < 0.05) differences in comparison to DMSO vehicle control.